Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS28P4 (Ribosomal protein S28 pseudogene 4) is a processed pseudogene located in the human genome, related to the protein-coding gene RPS28, which encodes a structural component of the 40S ribosomal subunit involved in cytoplasmic protein biosynthesis[7]. RPS28P4 does not code for a functional protein and does not have a known biological or pathological function. Its existence is a product of gene duplication or processing events, typical for pseudogenes derived from highly expressed genes like those encoding ribosomal proteins. Pseudogenes like RPS28P4 are not therapeutic targets. They are generally considered "genomic fossils" and, unless otherwise validated, are not implicated in cell biology, disease, or targeted by drugs[7]. Key notes on correctness: RPS28P4 is a pseudogene and should not be mistaken for RPS28, the protein-coding gene whose dysfunction is implicated in ribosomopathies such as Diamond-Blackfan anemia[1][3][5]. Only the parental gene, ribosomal protein S28 (RPS28), is a structural component of the ribosome and functionally relevant for protein synthesis and disease[1][3][5]. There is something wrong with this target if your intention is to obtain information on functional molecules or therapeutic targets. Summary: - RPS28P4 is a pseudogene, not a functional protein or receptor. - It is not a druggable target or a molecule directly involved in disease or cellular function. - There are no known aliases except for specific database identifiers[7]. - If you need information on ribosomal protein S28 (the functional molecule with therapeutic or biological significance), refer to RPS28 instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S28 pseudogene 4 (RPS28P4).